RESIST

A Study on the Best Course of Action Following Immunotherapy for Early-Stage Malignant Tumors of the Digestive Tract (Esophagus, Stomach, or Intestine)

Coordinating Investigator

  • Dieter Köberle

    Dieter Köberle

    Chefarzt Onkologie/Leiter der Medizinischen Klinik

The RESIST study is investigating the safety and efficacy of a structured, non-surgical management approach compared to the established standard surgical treatment.

Clinics

  • Luzerner Kantonsspital AG
    Luzerner Kantonsspital AG
  • St. Claraspital AG
    St. Claraspital AG